|Comparison of uncalibrated arterial waveform analysis in cardiac surgery patients with thermodilution cardiac output measurements.|
|Jump to Full Text|
|PMID: 17118186 Owner: NLM Status: MEDLINE|
|INTRODUCTION: Cardiac output (CO) monitoring is indicated only in selected patients. In cardiac surgical patients, perioperative haemodynamic management is often guided by CO measurement by pulmonary artery catheterisation (COPAC). Alternative strategies of CO determination have become increasingly accepted in clinical practice because the benefit of guiding therapy by data derived from the PAC remains to be proven and less invasive alternatives are available. Recently, a device offering uncalibrated CO measurement by arterial waveform analysis (COWave) was introduced. As far as this approach is concerned, however, the validity of the CO measurements obtained is utterly unclear. Therefore, the aim of this study was to compare the bias and the limits of agreement (LOAs) (two standard deviations) of COWave at four specified time points prior, during, and after coronary artery bypass graft (CABG) surgery with a simultaneous measurement of the gold standard COPAC and aortic transpulmonary thermodilution CO (COTranspulm). METHODS: Data from 30 patients were analysed during this prospective study. COPAC, COTranspulm, and COWave were determined in all patients at four different time points prior, during, and after CABG surgery. The COPAC and the COTranspulm were measured by triple injection of 10 ml of iced isotone sodium chloride solution into the central venous line of the PAC. Measurements of COWave were simultaneously taken at these time points. RESULTS: The overall correlation showed a Spearman correlation coefficient between COPAC and COWave of 0.53 (p < 0.01) and 0.84 (p < 0.01) for COPAC and COTranspulm. Bland-Altman analysis showed a mean bias and LOAs of 0.6 litres per minute and -2.2 to +3.4 litres per minute for COPAC versus COWave and -0.1 litres per minute and -1.8 to +1.6 litres per minute for COPAC versus COTranspulm. CONCLUSION: Arterial waveform analysis with an uncalibrated algorithm COWave underestimated COPAC to a clinically relevant extent. The wide range of LOAs requires further evaluation. Better results might be achieved with an improved new algorithm. In contrast to this, we observed a better correlation of thermodilution COTranspulm and thermodilution COPAC measurements prior, during, and after CABG surgery.|
|Michael Sander; Claudia D Spies; Herko Grubitzsch; Achim Foer; Marcus Müller; Christian von Heymann|
Related Documents :
|11711786 - Cardiomyopathy and pericardial tamponade in ulcerative colitis.
10172286 - New developments in perioperative cardiovascular monitoring.
834066 - Demonstration of a depressor reflex in acute cardiac tamponade.
3966956 - Doppler echocardiographic measurement of cardiac output using the mitral orifice method.
17133786 - Placement of two types of spiral z-stents at the bronchial carina for the treatment of ...
15342306 - Effectiveness of catheter ablation for coexisting atrial fibrillation and atrial flutter.
|Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't|
|Title: Critical care (London, England) Volume: 10 ISSN: 1466-609X ISO Abbreviation: Crit Care Publication Date: 2006|
|Created Date: 2007-02-08 Completed Date: 2007-03-26 Revised Date: 2009-11-18|
Medline Journal Info:
|Nlm Unique ID: 9801902 Medline TA: Crit Care Country: England|
|Languages: eng Pagination: R164 Citation Subset: IM|
|Department of Anesthesiology and Intensive Care Medicine, Charité University Medicine Berlin, Charité Campus Mitte, Campus Virchow Klinikum, Charitéplatz 1, 10117 Berlin, Germany. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Arteries / physiopathology*
Catheterization, Central Venous
Coronary Artery Bypass*
Sodium Chloride / administration & dosage
|0/Isotonic Solutions; 7647-14-5/Sodium Chloride|
|Crit Care. 2007;11(1):406; author reply 406
Journal ID (nlm-ta): Crit Care
Publisher: BioMed Central, London
Copyright ? 2006 Sander et al.; licensee BioMed Central Ltd.
open-access: This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received Day: 7 Month: 6 Year: 2006
Revision Requested Day: 28 Month: 6 Year: 2006
Revision Received Day: 30 Month: 8 Year: 2006
Accepted Day: 21 Month: 11 Year: 2006
Print publication date: Year: 2006
Electronic publication date: Day: 21 Month: 11 Year: 2006
Volume: 10 Issue: 6
First Page: R164 Last Page: R164
Publisher Id: cc5103
PubMed Id: 17118186
|Comparison of uncalibrated arterial waveform analysis in cardiac surgery patients with thermodilution cardiac output measurements|
|Michael Sander1||Email: firstname.lastname@example.org|
|Claudia D Spies1||Email: email@example.com|
|Herko Grubitzsch2||Email: firstname.lastname@example.org|
|Achim Foer1||Email: email@example.com|
|Marcus M?ller1||Email: MMueller-Eiche@gmx.de|
|Christian von Heymann1||Email: firstname.lastname@example.org|
1Department of Anesthesiology and Intensive Care Medicine, Charit? University Medicine Berlin, Charit? Campus Mitte, Campus Virchow Klinikum, Charit?platz 1, 10117 Berlin, Germany
2Department of Cardiovascular Surgery, Charit? University Medicine Berlin, Campus Charit? Mitte, Charit?platz 1, 10117 Berlin, Germany
Advanced haemodynamic monitoring is indicated only in selected patients. In cardiac surgical patients, perioperative haemodynamic management is often guided by cardiac output (CO) measurement using the pulmonary artery catheter (PAC). The use of the PAC, however, has been decreasing over the last years in surgical and cardiac surgical patients as the benefit of guiding therapy is doubtful. Furthermore, its usage might even be associated with increased morbidity . Other randomised studies did not provide clear evidence of benefit or harm by managing critically ill patients with a PAC [2,3]. Only some studies showed beneficial effect by guiding the therapy by PAC-derived data . Therefore, alternative strategies have been developed to measure CO. Aortic transpulmonary thermodilution (COTranspulm), a less invasive technique for determination of the CO, has become increasingly accepted in clinical practice [5-7]. Several investigators established a good correlation between these two methods of CO determination [5-8]. Most devices using transpulmonal thermodilution for CO determination also offer continuous CO determination by arterial pulse contour analysis. In these devices, the initial thermodilution measurement is used to calibrate the algorithm for the continuous CO measurement. Several methodological improvements of the algorithm [9,10] constituted the monitoring of the CO by calibrated continuous arterial pulse contour analysis as an alternative to PAC thermodilution CO (COPAC) in cardiac surgical patients [5,11], showing an accuracy comparable to that of pulmonary artery thermodilution [6,11,12].
Recently, a device offering uncalibrated CO measurement by arterial waveform analysis (COWave) (Vigileo; Edwards Lifesciences LLC, Irvine, CA, USA) was introduced. As far as this approach is concerned, however, the validity of the CO measurements obtained is utterly unclear. The software of this device calculates CO every 20 seconds on the basis of the last 20-second interval of arterial waveform analysis. The calibration coefficient adjusting for individual characteristics of the vascular resistance and the arterial compliance is re-calculated every 10 minutes on the basis of demographic data and the arterial waveform analysis.
Therefore, the aim of this study was to compare the bias and the limits of agreement (LOAs) (two standard deviations [SDs]) of COWave at four specified time points prior, during, and after coronary artery bypass graft (CABG) surgery with a simultaneous gold standard thermodilution measurement of COPAC and the thermodilution measurement of COTranspulm.
After ethical committee approval and written informed consent, 30 patients were considered eligible for this clinical trial from January to April 2006. Inclusion criteria were age more than 18 years and less than 80 years and elective CABG surgery. Exclusion criteria were withdrawal of consent, valve pathologies, left ventricular ejection fraction less than 40%, and symptomatic peripheral artery disease.
Oral premedication was with midazolam 0.1 mg/kg. A radial artery was placed in all patients prior to induction of anaesthesia. After induction, a femoral artery was cannulated with a 4-French cannula (Pulsiocath; Pulsion Medical Systems AG, Munich, Germany). A central venous catheter and a PAC (thermodilution catheter; Arrow International, Inc., Reading, PA, USA) were inserted via the right internal jugular vein.
General anaesthesia was induced with etomidate 0.2 mg/kg, fentanyl 5 ?g/kg, and pancuronium 0.1 mg/kg. Maintenance was with infusion of fentanyl 5 to 10 ?g/kg per hour, boluses of midazolam 0.1 mg/kg, pancuronium 0.03 mg/kg, and 0.6% to 1% end-tidal isoflurane. All patients were ventilated with an oxygen-air mixture (FiO2 [inspiratory oxygen fraction] 0.5) to maintain an end-tidal pCO2 (partial pressure of carbon dioxide) of 35 to 45 mm Hg. Cardiopulmonary bypass (CPB) technique was normothermic using intermittent antegrade warm blood cardioplegia as described by Calafiore and colleagues . Transfusion management was performed according to our standard operating procedure . Durations of anaesthesia, surgery, and aortic occlusion and number of CABGs were recorded.
CO was determined at four time points. The first measurement was performed after induction of anaesthesia and placement of the catheters. The second measurement was performed 15 minutes after sternotomy prior to CPB. The third and fourth measurements were performed one hour after admission to the intensive care unit (ICU) and six hours after admission to the ICU, respectively. A stable haemodynamic condition was a prerequisite for the measurements. Therefore, infusion of large volumes of colloids or cristalloids or the bolus administration of vasopressors was not permitted during the measurements. The COPAC and the COTranspulm were measured by triple injection of 10 ml of iced isotone sodium chloride solution into the central venous line of the PAC. The COPAC and the COTranspulm were calculated by commercially available monitors (CCO module, Solar 8000; Marquette Hellige GmbH, Freiburg, Germany, and PiCCO CCO monitor; Pulsion Medical Systems AG, M?nchen, Germany). In case of a deviation of more than 10% of a measurement, five measurements were performed and the highest and lowest were rejected. The COPAC and the COTranspulm measurements were carried out simultaneously.
The measurement of COWave was performed by arterial waveform analysis without any external calibration by using a commercially available transducer (FloTrac; Edwards Lifesciences LLC), which links the radial arterial line with the monitor (Vigileo; Edwards Lifesciences LLC). A stable haemodynamic condition with no damping of the arterial pressure line, which could be achieved in all patients, was also a prerequisite for this measurement. For each measurement of COPAC and COTranspulm, a corresponding simultaneous COWave was documented.
All data are expressed as mean and standard error of the mean. Statistical analysis was performed by linear regression analysis. Bias and LOAs (two SDs) were assessed according to the method described by Bland and Altman . The percentage error was calculated according to the method described by Critchley and Critchley . All numerical calculations were carried out with SPSS for Windows, Release 11.5.1 (SPSS Inc., Chicago, IL, USA).
During this study, we evaluated CO using three different methods. To do so, we performed 120 measurements of CO in 30 patients at four different time points. In one patient, inserting the PAC was impossible. In another patient, we were unable to place the arterial thermodilution catheter. Due to technical problems with the transducer, the uncalibrated arterial waveform CO could not be analysed in six measurements in five patients. In one patient, postoperative measurements were impossible because this patient received an intra-aortic balloon pump for weaning from CPB. As a result, we were able to analyse 110 paired measurements comparing COPAC with COTranspulm and 108 paired measurements comparing COPAC with COWave.
Anaesthesia and surgery were uncomplicated in all patients. Patients' basic characteristics are given in Table 1. Surgery- and ICU-related data are also provided in Table 1. Haemodynamic data are provided in Table 2. Heart rate increased significantly at all points of measurement compared with baseline values (p < 0.01). Only prior to CPB was the central venous pressure significantly decreased compared with the baseline measurement (p = 0.04). The overall correlation between COPAC and COWave was 0.53 (p < 0.01) (Figure 1), whereas the overall correlation between COPAC and COTranspulm was 0.84 (p < 0.01) (Figure 1). Bland-Altman analysis showed a mean bias and LOAs of 0.6 litres per minute and -2.2 to +3.4 litres per minute for COPAC versus COWave (Figure 1) and -0.1 litres per minute and -1.8 to +1.6 litres per minute for COPAC versus COTranspulm. The percentage errors for COPAC versus COWave and for COPAC versus COTranspulm were 54% and 30%, respectively.
Prior to surgery, COPAC and COWave showed a correlation coefficient of 0.54 (p < 0.01) and COPAC and COTranspulm a coefficient of 0.78 (p < 0.01) (Figure 2). Bland-Altman analysis for COPAC versus COWave showed a mean bias and LOAs of 0.2 litres per minute and -2.6 to +3.0 litres per minute and COPAC versus COTranspulm of 0.2 litres per minute and -1.2 to +1.6 litres per minute (Figure 3). The percentage errors for COPAC versus COWave and for COPAC versus COTranspulm were 58% and 32%, respectively. There was no correlation between COPAC and COWave (correlation coefficient of 0.29) (Figure 2), whereas the correlation coefficient between COPAC and COTranspulm prior to CPB was 0.74 (p < 0.01). At this time point, the Bland-Altman analysis showed a mean bias and LOAs of +1.0 litres per minute and -2.6 to +4.6 litres per minute for COPAC versus COWave and 0.1 litres per minute and -1.3 to +1.5 litres per minute for COPAC versus COTranspulm (Figure 3). The percentage errors for COPAC versus COWave and for COPAC versus COTranspulm were 70% and 25%, respectively.
After admission to the ICU, COPAC versus COWave and COPAC versus COTranspulm showed a reasonable correlation, with correlation coefficients of 0.69 (p < 0.01) and 0.68 (p < 0.01), respectively (Figure 2). Bland-Altman analysis established a mean bias and LOAs of 0.7 litres per minute and -1.3 to +2.7 litres per minute versus -0.4 litres per minute and -2.6 to +1.8 litres per minute, respectively (Figure 3). The percentage errors for COPAC versus COWave and for COPAC versus COTranspulm were 36% and 36%, respectively. Six hours after ICU admission, the comparison of COPAC versus COWave and COPAC versus COTranspulm resulted in correlation coefficients of 0.36 (not significant) and 0.88 (p < 0.01), respectively (Figure 2). Bland-Altman analysis showed a mean bias and LOAs of -0.5 litres per minute and -1.7 to +0.7 litres per minute versus 0.6 litres per minute and -2.2 to +3.4 litres per minute, respectively (Figure 3). The percentage errors for COPAC versus COWave and for COPAC versus COTranspulm were 48% and 19%, respectively.
The change in CO between two subsequent measurements prior to surgery and prior to CPB, prior to CPB and admission to the ICU, and between admission to the ICU and six hours later were, for COPAC, 1.2 (1.5), -0.2 (1.8), and 0.3 (1.4), respectively. The changes for COWave were 0.4 (2.0), 0.4 (1.4), and 0.2 (1.3), respectively. For the change of COTranspulm, the corresponding values were 1.3 (1.6), 0.4 (1.6), and 0.3 (1.4), respectively. Correlation coefficients of the change in COPAC versus COWave and COPAC versus COTranspulm between measurements prior to surgery and prior to CPB were 0.55 (p < 0.01) and 0.82 (p < 0.01), respectively. Between measurements prior to CPB and admission to the ICU, the coefficients were 0.51 (p = 0.2) and 0.67 (p < 0.01), respectively, and 0.60 (p < 0.01) and 0.44 (p = 0.05), respectively, for measurements between admission to the ICU and six hours later.
This is the first study evaluating a new method of estimating uncalibrated arterial waveform CO in comparison with two standard methods of CO determination. The most important finding of our study was that intraoperative and early postoperative CO measurements by the uncalibrated arterial waveform analysis showed a high bias and a wide range of LOAs in comparison with the COPAC measurement, which was the reference method in this study. In contrast, we found a better correlation between COPAC and transpulmonal thermodilution CO measurement COTranspulm.
In this study, we evaluated the FloTrac sensor and the Vigileo monitor system for continuous monitoring of CO. This system does not require thermodilution or dye dilution. Rather, it bases its calculations on arterial waveform characteristics in conjunction with patient demographic data. The software for this device calculates CO every 20 seconds on the basis of the last 20-second interval of arterial waveform analysis. The calibration coefficient adjusting for individual characteristics of the vascular resistance and the arterial compliance is re-calculated every 10 minutes on the basis of demographic data and the arterial waveform analysis. In contrast to similar devices analysing the arterial waveform, this device does not require calibration with another method  and uses a radial artery only. So far, however, there have not been any controlled peer-reviewed studies comparing this method with standard methods of CO determination.
This trial investigated the validity of continuous CO measurement by uncalibrated arterial waveform analysis compared with standard techniques (COPAC and COTranspulm) prior, during, and after CABG surgery. We could demonstrate that all techniques of CO measurement have their technical limitations, including difficulties with correct catheter placement, transducer malfunction, and CO monitor malfunction. In our intraoperative and early postoperative setting in patients undergoing cardiac surgery, we found the use of the PAC with fast determination of the CO by thermodilution and high precision within one set of measurement was the best alternative of CO determination. The main practical advantage of COWave measurement in this setting is that it is a quick and easy way of determining CO. The algorithm of the CO monitor automatically starts to determine the CO by continuous arterial waveform analysis in all patients with pulsatile flow. Therefore, in the setting of CABG surgery, haemodynamic monitoring using a pulse contour device with a fast and continuous approach might be practical and advantageous for haemodynamic-oriented therapy. The anaesthetist can direct his/her full attention on vasoactive and volume therapy, which might sometimes be necessary in unstable CABG patients in the perioperative period, rather than be involved in cumbersome, time-consuming, intermitted thermodilution techniques of CO determination. These advantages are, however, only relevant if the data obtained are valid.
Overall analysis of all COWave measurements pooled failed to show a clinically acceptable correlation and LOAs in comparison with the total of COPAC measurements. We were unable to show a reliable correlation between COPAC and COWave prior to CPB and six hours after admission to the ICU. The best correlation was observed one hour after admission to the ICU, with a correlation coefficient of 0.68. Even at this time point, however, the bias and the LOAs were unacceptably high (0.7 litres per minute and -1.3 to +2.7 litres per minute). This was, however, the only time point when the bias and the LOAs between COPAC and COTranspulm were also unacceptably high (-0.4 litres per minute and -2.6 to +1.8 litres per minute). All other measurements between COPAC and COTranspulm showed clinically acceptable bias and LOAs. As far as we know, there are no other controlled studies investigating uncalibrated arterial waveform analysis in comparison with standard methods of CO determination.
Pulse contour analysis CO has been established as a valid and cost-effective device for CO determination after calibration [18,19]. Most devices providing continuous pulse contour analysis, however, need calibration by an independent method of CO measurement. After calibration by either thermodilution or lithium dilution CO measurement, pulse contour CO algorithms displayed a clinically acceptable bias and LOAs [6,18,20].
Previous investigations with calibrated pulse contour analysis showed only a reasonable correlation with thermodilution methods of CO determination, with a bias and LOAs of -0.2 litres per minute and -2.2 to +2.6 litres per minute after cardiac surgery . Therefore, we suggest that CO determination with pulse contour analysis in a setting after cardiac surgery might not be the ideal method . Uncalibrated arterial waveform analysis in this setting might even yield worse results. This conclusion is in line with our findings.
We compared overall calibrated COTranspulm measurement performed by aortic transpulmonary CO determination with overall COPAC. We found a better correlation between the COTranspulm and the COPAC [5,6,22] with the exception of the time point one hour after admission to the ICU. The greater scatter between the two CO measurements after admission to the ICU compared with all other measurements may have been the influx of cooler blood derived from compartments, which might be hypoperfused during and early after CPB and then reperfused during the first hours after surgery as suggested by previous investigators [5,23]. A decrease in body temperature worsens the signal-to-noise ratio of the thermal indicator used for determination of the CO by these methods. In this setting, better results might be achieved by using an indicator independent from thermal signals.
A limitation of our study concept is that we do not know the 'true' CO. Bearing in mind, however, that we did find a rather good correlation for the two thermodilution measurements, we assume that thermodilution-derived CO determination represents a reliable estimation of the 'true' CO in clinical practice. The use of the radial artery for COWave determination, which was in line with the recommendations of the manufacturer, might have influenced the accuracy of the CO determination due to vasoconstriction. However, because no patient received continuous norepinephrine, we suggest that vasoconstriction might not be the main factor influencing the accuracy of the CO determination with this method.
Our study of arterial waveform analysis with an uncalibrated algorithm showed that COWave underestimated COPAC to a clinically relevant extent in the difficult setting prior, during, and early after CABG surgery with the software used in this study. The wide range of LOAs requires further evaluation. In contrast to this, we observed a better correlation of calibrated COTranspulm and COPAC measurements prior, during, and after CABG surgery.
The bias and LOAs of COWave need to be evaluated in different settings against standard methods of CO measurements to prevent patients from being exposed to wrong therapeutic decisions. However, the new software version of this device, featuring a shorter recalibration period, might lead to better results and has to be re-evaluated in this setting.
? We observed a good correlation of COTranspulm and COPAC measurements prior, during, and after CABG surgery.
? Our study could not establish pulse contour analysis with an uncalibrated pulse contour algorithm to be a method yielding reliable results under difficult conditions in perioperative CABG patients.
? COWave underestimated COPAC and showed a wide range of LOAs, requiring further clinical evaluation in different patient populations.
CABG = coronary artery bypass graft; CO = cardiac output; COPAC = pulmonary artery catheter thermodilution cardiac output; COTranspulm = aortic transpulmonary thermodilution cardiac output; COWave = uncalibrated pulse contour cardiac output; CPB = cardiopulmonary bypass; ICU = intensive care unit; LOA = limit of agreement; PAC = pulmonary artery catheter; SD = standard deviation.
This study was financially supported by Edwards Lifesciences LLC.
MS and CvH prepared the manuscript, carried out the cardiac output measurements, conceived the study, and performed the statistical analysis. AF and MM helped with the recruitment of the patients and the drafting of the manuscript. HG participated in the study design and helped with the recruitment of patients. CS drafted the manuscript and helped with the study design and coordination. All authors read and approved the final manuscript.
The authors appreciate the diligent linguistic revision of this manuscript by Mrs. Sirka Sander, sworn and certified translator of the English language. This study was financially supported by an unrestricted research grant from Edwards Lifesciences LLC, departmental funding, and institutional research grants of the Charit? Medical School (Charit? Universit?tsmedizin Berlin).
|Connors AF Jr,Speroff T,Dawson NV,Thomas C,Harrell FE Jr,Wagner D,Desbiens N,Goldman L,Wu AW,Califf RM,et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT InvestigatorsJAMA 1996;276:889–897. [pmid: 8782638] [doi: 10.1001/jama.276.11.889]|
|Richard C,Warszawski J,Anguel N,Deye N,Combes A,Barnoud D,Boulain T,Lefort Y,Fartoukh M,Baud F,et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trialJAMA 2003;290:2713–2720. [pmid: 14645314] [doi: 10.1001/jama.290.20.2713]|
|Harvey S,Harrison DA,Singer M,Ashcroft J,Jones CM,Elbourne D,Brampton W,Williams D,Young D,Rowan K. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trialLancet 2005;366:472–477. [pmid: 16084255] [doi: 10.1016/S0140-6736(05)67061-4]|
|Polonen P,Ruokonen E,Hippelainen M,Poyhonen M,Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patientsAnesth Analg 2000;90:1052–1059. [pmid: 10781452]|
|Rauch H,Muller M,Fleischer F,Bauer H,Martin E,Bottiger BW. Pulse contour analysis versus thermodilution in cardiac surgery patientsActa Anaesthesiol Scand 2002;46:424–429. [pmid: 11952444] [doi: 10.1034/j.1399-6576.2002.460416.x]|
|Godje O,Hoke K,Goetz AE,Felbinger TW,Reuter DA,Reichart B,Friedl R,Hannekum A,Pfeiffer UJ. Reliability of a new algorithm for continuous cardiac output determination by pulse-contour analysis during hemodynamic instabilityCrit Care Med 2002;30:52–58. [pmid: 11902287] [doi: 10.1097/00003246-200201000-00008]|
|Sakka SG,Reinhart K,Meier-Hellmann A. Comparison of pulmonary artery and arterial thermodilution cardiac output in critically ill patientsIntensive Care Med 1999;25:843–846. [pmid: 10447543] [doi: 10.1007/s001340050962]|
|Buhre W,Weyland A,Kazmaier S,Hanekop GG,Baryalei MM,Sydow M,Sonntag H. Comparison of cardiac output assessed by pulse-contour analysis and thermodilution in patients undergoing minimally invasive direct coronary artery bypass graftingJ Cardiothorac Vasc Anesth 1999;13:437–440. [pmid: 10468257] [doi: 10.1016/S1053-0770(99)90216-1]|
|Jansen JR,Wesseling KH,Settels JJ,Schreuder JJ. Continuous cardiac output monitoring by pulse contour during cardiac surgeryEur Heart J 1990;11(Suppl I):26–32. [pmid: 2092987]|
|Wesseling KH,Jansen JR,Settels JJ,Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element modelJ Appl Physiol 1993;74:2566–2573. [pmid: 8335593]|
|Zollner C,Haller M,Weis M,Morstedt K,Lamm P,Kilger E,Goetz AE. Beat-to-beat measurement of cardiac output by intravascular pulse contour analysis: a prospective criterion standard study in patients after cardiac surgeryJ Cardiothorac Vasc Anesth 2000;14:125–129. [pmid: 10794327] [doi: 10.1016/S1053-0770(00)90003-X]|
|Della RG,Costa MG,Pompei L,Coccia C,Pietropaoli P. Continuous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary techniqueBr J Anaesth 2002;88:350–356. [pmid: 11990265] [doi: 10.1093/bja/88.3.350]|
|Calafiore AM,Teodori G,Mezzetti A,Bosco G,Verna AM,Di Giammarco G,Lapenna D. Intermittent antegrade warm blood cardioplegiaAnn Thorac Surg 1995;59:398–402. [pmid: 7847955] [doi: 10.1016/0003-4975(94)00843-V]|
|von Heymann C. Spies CD, Kox WJTherapy with blood and blood componentsCheck-up An?sthesiologie 2004Berlin: Springer; :400–402.|
|Bland JM,Altman DG. Statistical methods for assessing agreement between two methods of clinical measurementLancet 1986;1:307–310. [pmid: 2868172]|
|Critchley LA,Critchley JA. A meta-analysis of studies using bias and precision statistics to compare cardiac output measurement techniquesJ Clin Monit Comput 1999;15:85–91. [pmid: 12578081] [doi: 10.1023/A:1009982611386]|
|Manecke GR. Edwards FloTrac sensor and Vigileo monitor: easy, accurate, reliable cardiac output assessment using the arterial pulse waveExpert Rev Med Devices 2005;2:523–527. [pmid: 16293062] [doi: 10.1586/174344188.8.131.523]|
|Godje O,Friedl R,Hannekum A. Accuracy of beat-to-beat cardiac output monitoring by pulse contour analysis in hemodynamical unstable patientsMed Sci Monit 2001;7:1344–1350. [pmid: 11687755]|
|Penttila J,Snapir A,Kentala E,Koskenvuo J,Posti J,Scheinin M,Scheinin H,Kuusela T. Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methodsEur J Clin Pharmacol 2006;62:401–407. [pmid: 16570186] [doi: 10.1007/s00228-006-0115-1]|
|Pittman J,Bar-Yosef S,SumPing J,Sherwood M,Mark J. Continuous cardiac output monitoring with pulse contour analysis: a comparison with lithium indicator dilution cardiac output measurementCrit Care Med 2005;33:2015–2021. [pmid: 16148474] [doi: 10.1097/01.CCM.0000179021.36805.1F]|
|Sander M,von Heymann C,Foer A,von Dossow V,Grosse J,Dushe S,Konertz WF,Spies CD. Pulse contour analysis after normothermic cardiopulmonary bypass in cardiac surgery patientsCrit Care 2005;9:R729–R734. [pmid: 16356221] [doi: 10.1186/cc3903]|
|Jellema WT,Wesseling KH,Groeneveld AB,Stoutenbeek CP,Thijs LG,van Lieshout JJ. Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilutionAnesthesiology 1999;90:1317–1328. [pmid: 10319780] [doi: 10.1097/00000542-199905000-00016]|
|Latson TW,Whitten CW,O'Flaherty D. Ventilation, thermal noise, and errors in cardiac output measurements after cardiopulmonary bypassAnesthesiology 1993;79:1233–1243. [pmid: 8267199] [doi: 10.1097/00000542-199312000-00014]|
Patients' basic characteristics and surgery-related data
|Body mass index (kg/m2)||30||27||2.8|
|Urine volume during CPB (ml)||30||391||185|
|Urine volume during surgery (ml)||30||1,030||324|
|Duration of anaesthesia (minutes)||30||312||56|
|Duration of surgery (minutes)||30||208||52|
|CPB time (minutes)||30||91||29|
|Aortic cross-clamp time (minutes)||30||55||23|
|APACHE II score||30||16||6|
APACHE, acute physiology and chronic health evaluation; CPB, cardiopulmonary bypass; SD, standard deviation.
|After induction of anaesthesia|
|Heart rate (beats per minute)||30||69||16|
|MAP (mm Hg)||30||71||15|
|PMAP (mm Hg)||30||19||5|
|CVP (mm Hg)||30||9||5|
|PVR (dyn/s per cm-5)||30||184||245|
|SVR (dyn/s per cm-5)||30||1,031||342|
|Heart rate (beats per minute)||30||76*||12|
|MAP (mm Hg)||30||68||13|
|PMAP (mm Hg)||30||19||5|
|CVP (mm Hg)||30||7*||4|
|PVR (dyn/s per cm-5)||30||325||492|
|SVR (dyn/s per cm-5)||30||945||338|
|One hour after admission to ICU|
|Heart rate (beats per minute)||30||79*||15|
|MAP (mm Hg)||30||72||13|
|PMAP (mm Hg)||30||21||6|
|CVP (mm Hg)||30||9||5|
|PVR (dyn/s per cm-5)||30||225||463|
|SVR (dyn/s per cm-5)||30||938||220|
|Six hours after admission to ICU|
|Heart rate (beats per minute)||30||81*||13|
|MAP (mm Hg)||30||73||10|
|PMAP (mm Hg)||30||21||7|
|CVP (mm Hg)||30||9||5|
|PVR (dyn/s per cm-5)||30||128||48|
|SVR (dyn/s per cm-5)||30||914||280|
*significant change compared to baseline. COPAC, pulmonary artery catheter thermodilution cardiac output; COTranspulm, aortic transpulmonary thermodilution cardiac output; COWave, uncalibrated pulse contour cardiac output; CVP, central venous pressure; ICU, intensive care unit; MAP, mean arterial pressure; PMAP, peripheral mean arterial pressure; PVR, pulmonary vascular resistance; SD, standard deviation; SVR, systemic vascular resistance.
Previous Document: Giant solitary fibrous tumour of the liver.
Next Document: The competent sentinel node: an association with an axillary presentation and an occult or a small p...